$ERIE Etches An All-Time High

DexCom Dives -40%

July 28, 2024

Good evening. Welcome to Trends with No Friends.

We have some business before we dive in...

Trends with No Friends is nearly a year old! To celebrate, we’re cooking up a few new features that I cannot wait to share, but as we continue to grow please send ideas you have as to how we can improve and what additional insights you’d like to see.

Onward…

FOR THOSE JUST JOINING US, HERE’S AN OVERVIEW

Trends With No Friends sifts through the noise and discovers stocks above $1B market cap with high relative strength and low Stocktwits following.

Why is this combination important?

Stocks that are outperforming tend to continue to outperform. Stocks that have a low Stocktwits following are, by definition, undiscovered by the crowd. Stocks that have both Relative Strength and Low Stocktwits Following can really outperform as more investors discover them.

They are ripe to rip.

Stocks finished the week strong. Every major index advanced more than +1%. The Dow and Russell 2000 ripped +1.60%.

Every sector closed higher. Communications, industrials, real estate, basic materials and financials flew more than +1.50%.

New 52-Week Highs led New Lows — 265 vs. 12.

THE BEST OF THE BEST

Erie Indemnity ($ERIE) is the Best of the Best. The $20B insurance company carried +8.74% following its Q2 earnings report.

$ERIE etched an all-time high.

Here’s the daily chart.

And weekly chart.

THE WORST OF THE WORST

DexCom ($DXCM) is the Worst of the Worst. The medical device company cratered -40.66% following its disasterous Q2 earnings report.

$DXCM closed at its lowest price since April 2020.

Here’s the daily chart.

And weak weekly chart.

52 WEEK HIGHS

52 WEEK LOWS

RILEY’S RECS

GET IN TOUCH

Email me (Riley Rosebee) your feedback; I’d love to hear from you. 📧

Want to sponsor this newsletter and reach thousands of passionate investors and traders? Reach us here. 👍

Disclaimer: Stocktwits, Inc. (“Stocktwits”) operates the stocktwits.com website and Stocktwits mobile device applications (the “Apps”). Stocktwits is not a securities broker-dealer, investment adviser, or any other type of financial professional. No content on the Stocktwits platform should be considered an offer, solicitation of an offer, or advice to buy or sell securities or any other type of investment or financial product. Read the full terms & conditions here. 🔍

Reply

or to participate.